IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

OUP Management Co., LLC

Q2 2022 Holdings

Filed 2022-07-19 | 15 holdings | $72.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals plc(CNTA)Sponsored ADS152309100$14.3K2,937,61519.7%
PMV Pharmaceuticals, Inc.(PMVP)Common Stock69353Y103$14.1K989,23219.4%
Aerovate Therapeutics Inc.Common Stock008064107$9.4K603,76213.0%
Dice Therapeutics Inc.Common Stock23345J104$8.3K536,69311.5%
Cyteir Therapeutics, Inc.Common Stock23284P103$7.4K2,474,57210.2%
ionQ, Inc.(IONQ)Common Stock46222L108$6.0K1,377,5978.3%
Evolv Technologies Holdings, Inc.(EVLV)Common Stock30049H102$4.2K1,582,7215.8%
Vor Biopharma Inc.Common Stock929033108$1.9K374,7142.6%
Precision BioSciences, Inc.Common Stock74019P108$1.8K1,123,9132.5%
eFFECTOR Therapeutics, Inc.Common Stock28202V108$1.5K1,025,6972.0%
Landos Biopharma, Inc.Common Stock515069102$1.2K1,612,7641.6%
Selecta Biosciences, Inc.(SELBUSD)Common Stock816212104$1.1K862,5431.6%
Graphite Bio(GRPH)Common Stock38870X104$1.1K406,3081.5%
Spero Therapeutics, Inc.(SPRO)Common Stock84833T103$185249,0700.3%
Homology Medicines, Inc.Common Stock438083107$12664,0000.2%